nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabigatran etexilate—F2—Common Pathway—F13B—age related macular degeneration	0.103	0.103	CbGpPWpGaD
Dabigatran etexilate—F2—Blood Clotting Cascade—F13B—age related macular degeneration	0.0879	0.0879	CbGpPWpGaD
Dabigatran etexilate—F2—Intrinsic Pathway—SERPING1—age related macular degeneration	0.0827	0.0827	CbGpPWpGaD
Dabigatran etexilate—F2—Formation of Fibrin Clot (Clotting Cascade)—F13B—age related macular degeneration	0.0593	0.0593	CbGpPWpGaD
Dabigatran etexilate—F2—Formation of Fibrin Clot (Clotting Cascade)—SERPING1—age related macular degeneration	0.0557	0.0557	CbGpPWpGaD
Dabigatran etexilate—F2—Complement and Coagulation Cascades—F13B—age related macular degeneration	0.0399	0.0399	CbGpPWpGaD
Dabigatran etexilate—F2—Complement and Coagulation Cascades—C9—age related macular degeneration	0.0375	0.0375	CbGpPWpGaD
Dabigatran etexilate—F2—Complement and Coagulation Cascades—SERPING1—age related macular degeneration	0.0375	0.0375	CbGpPWpGaD
Dabigatran etexilate—F2—Complement and Coagulation Cascades—CFI—age related macular degeneration	0.0325	0.0325	CbGpPWpGaD
Dabigatran etexilate—F2—Complement and Coagulation Cascades—C2—age related macular degeneration	0.027	0.027	CbGpPWpGaD
Dabigatran etexilate—F2—Complement and Coagulation Cascades—CFH—age related macular degeneration	0.0226	0.0226	CbGpPWpGaD
Dabigatran etexilate—F2—Complement and Coagulation Cascades—CFB—age related macular degeneration	0.0219	0.0219	CbGpPWpGaD
Dabigatran etexilate—F2—Cell surface interactions at the vascular wall—SLC16A8—age related macular degeneration	0.02	0.02	CbGpPWpGaD
Dabigatran etexilate—CES2—NRF2 pathway—SQSTM1—age related macular degeneration	0.0179	0.0179	CbGpPWpGaD
Dabigatran etexilate—ABCB1—ABC-family proteins mediated transport—ABCG4—age related macular degeneration	0.0175	0.0175	CbGpPWpGaD
Dabigatran etexilate—ABCB1—ABC-family proteins mediated transport—ABCA4—age related macular degeneration	0.0156	0.0156	CbGpPWpGaD
Dabigatran etexilate—F2—Post-translational protein modification—B3GLCT—age related macular degeneration	0.014	0.014	CbGpPWpGaD
Dabigatran etexilate—F2—IL1 and megakaryotyces in obesity—CCL2—age related macular degeneration	0.0137	0.0137	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—SERPING1—age related macular degeneration	0.0131	0.0131	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—ELOVL4—age related macular degeneration	0.0117	0.0117	CbGpPWpGaD
Dabigatran etexilate—CES1—NRF2 pathway—SQSTM1—age related macular degeneration	0.0105	0.0105	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—CRP—age related macular degeneration	0.0091	0.0091	CbGpPWpGaD
Dabigatran etexilate—F2—Post-translational protein modification—ADAMTS9—age related macular degeneration	0.00899	0.00899	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—APOE—age related macular degeneration	0.0089	0.0089	CbGpPWpGaD
Dabigatran etexilate—F2—Complement and Coagulation Cascades—C3—age related macular degeneration	0.00851	0.00851	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—CCL2—age related macular degeneration	0.00748	0.00748	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—CRP—age related macular degeneration	0.0074	0.0074	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—F13B—age related macular degeneration	0.00716	0.00716	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.00693	0.00693	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—SERPING1—age related macular degeneration	0.00673	0.00673	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—SKIV2L—age related macular degeneration	0.00662	0.00662	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—B3GLCT—age related macular degeneration	0.00662	0.00662	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—NMNAT1—age related macular degeneration	0.00639	0.00639	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—CCL2—age related macular degeneration	0.00609	0.00609	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—NRF2 pathway—SQSTM1—age related macular degeneration	0.00605	0.00605	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00588	0.00588	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—RAD51B—age related macular degeneration	0.00583	0.00583	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—ELOVL4—age related macular degeneration	0.00559	0.00559	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—SLC16A8—age related macular degeneration	0.00542	0.00542	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—RHO—age related macular degeneration	0.00528	0.00528	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—NRF2 pathway—SQSTM1—age related macular degeneration	0.00492	0.00492	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.00484	0.00484	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00464	0.00464	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—SLC16A8—age related macular degeneration	0.0045	0.0045	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—ADAMTS9—age related macular degeneration	0.00427	0.00427	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—PPARA activates gene expression—CD36—age related macular degeneration	0.00414	0.00414	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—age related macular degeneration	0.00405	0.00405	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—C3—age related macular degeneration	0.00334	0.00334	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.00312	0.00312	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—RHO—age related macular degeneration	0.00298	0.00298	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—NMNAT1—age related macular degeneration	0.00291	0.00291	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—age related macular degeneration	0.00279	0.00279	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—RHO—age related macular degeneration	0.00271	0.00271	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—CCL2—age related macular degeneration	0.00261	0.00261	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—RDH8—age related macular degeneration	0.00261	0.00261	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ELOVL4—age related macular degeneration	0.00254	0.00254	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—NMNAT1—age related macular degeneration	0.00237	0.00237	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—C3—age related macular degeneration	0.00234	0.00234	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—LIPC—age related macular degeneration	0.0023	0.0023	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—RPE65—age related macular degeneration	0.00228	0.00228	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00224	0.00224	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.00224	0.00224	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—CETP—age related macular degeneration	0.00222	0.00222	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ELOVL4—age related macular degeneration	0.00207	0.00207	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—SLC16A8—age related macular degeneration	0.00205	0.00205	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.00201	0.00201	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00192	0.00192	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00185	0.00185	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ABCA4—age related macular degeneration	0.00184	0.00184	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00183	0.00183	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00175	0.00175	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—C3—age related macular degeneration	0.00171	0.00171	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—SLC16A8—age related macular degeneration	0.00167	0.00167	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00163	0.00163	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00163	0.00163	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—CD36—age related macular degeneration	0.00161	0.00161	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—RHO—age related macular degeneration	0.0016	0.0016	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.00149	0.00149	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—VEGFA—age related macular degeneration	0.00136	0.00136	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—CD36—age related macular degeneration	0.00134	0.00134	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CCL2—age related macular degeneration	0.00133	0.00133	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—APOE—age related macular degeneration	0.00118	0.00118	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—VEGFA—age related macular degeneration	0.00118	0.00118	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00111	0.00111	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—NMNAT1—age related macular degeneration	0.00108	0.00108	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—LIPC—age related macular degeneration	0.00105	0.00105	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CETP—age related macular degeneration	0.00101	0.00101	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00098	0.00098	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—C3—age related macular degeneration	0.000964	0.000964	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ELOVL4—age related macular degeneration	0.000948	0.000948	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—CCL2—age related macular degeneration	0.000939	0.000939	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TGFBR1—age related macular degeneration	0.000898	0.000898	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—C3—age related macular degeneration	0.000875	0.000875	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—LIPC—age related macular degeneration	0.000853	0.000853	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CETP—age related macular degeneration	0.000823	0.000823	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—SQSTM1—age related macular degeneration	0.000814	0.000814	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000806	0.000806	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—VEGFA—age related macular degeneration	0.000766	0.000766	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SLC16A8—age related macular degeneration	0.000764	0.000764	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CCL2—age related macular degeneration	0.000685	0.000685	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CD36—age related macular degeneration	0.000609	0.000609	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000581	0.000581	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—APOE—age related macular degeneration	0.000537	0.000537	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—C3—age related macular degeneration	0.000517	0.000517	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CD36—age related macular degeneration	0.000495	0.000495	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—APOE—age related macular degeneration	0.000481	0.000481	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—KDR—age related macular degeneration	0.000472	0.000472	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—APOE—age related macular degeneration	0.000436	0.000436	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCL2—age related macular degeneration	0.000405	0.000405	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—LIPC—age related macular degeneration	0.000391	0.000391	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CETP—age related macular degeneration	0.000378	0.000378	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—VEGFA—age related macular degeneration	0.00026	0.00026	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CD36—age related macular degeneration	0.000227	0.000227	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—APOE—age related macular degeneration	0.0002	0.0002	CbGpPWpGaD
